<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Cytoskeleton Mycotoxins Proteins FcεRI Lipid raft Cytochalasin Fc receptor RBL cells Immunoglobulin E Biology Immune system Cell biology |
| Curing Allergic Diseases S-TARget therapeutics GmbH Mooslackengasse 17, 1190 Vienna, Austria. Phone:+, +, +ConfidentialDocID: 1rgTJ - View Document |
| SuppreMol_Crawford Release ENG_Mar 4, 2015DocID: 1qGKf - View Document |
| Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti-IL-5 receptor α antibody, in a phase I study of patients with mild asthmaDocID: 1qDqa - View Document |
| KASCHE & PARTNER AG INTELLECTUAL PROPERTY Dr. André Kasche Dr. Oliver HorlacherDocID: 1qxAK - View Document |
| Validation of Peptide Immunotherapy as a New Approach in the Treatment of Allergic Rhinoconjunctivitis: The Clinical Benefits of Treatment with Amb a 1 Derived T cell EpitopesDocID: 1qs00 - View Document |